← Leaderboards
Jerry William Shay
American Association For Cancer Research
$8,893,552
Attributed
$9,323,176
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,117,867 · 9
By mechanism
T32$6,129,736 · 2
U19$3,794,691 · 1
P50$1,902,239 · 2
P30$891,951 · 2
R01$394,250 · 1
R13$5,000 · 1
Top collaborators
- David M. Ashley5 shared
- Rolf A Brekken2 shared
Others in their field
Top investigators on “Cancer Biology”
- David Heimbrook · Leidos Biomedical Research, Inc.$733,635,275
- Leonard Freedman · Leidos Biomedical Research, Inc.$380,818,284
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$296,212,246
- Gregory H Reaman · National Childhood Cancer Foundation$270,366,096
- Peter C Adamson · National Childhood Cancer Foundation$234,478,679
- Richard A Gibbs · Baylor College Of Medicine$225,148,852
Research focus
Cancer BiologyGrantTrainingChemotherapyTelomeraseMalignant NeoplasmsResponseClinical TrialsIn VivoTumorUniversitiesTexasPre-ClinicalFutureInstitutionBaseLeadResistancePreclinical StudySafetyCellsMouse ModelNeoplastic CellMalignant Neoplasm Of Lung
Grant awards (40)
6-thio-2'-deoxyguanosine: A Novel Immunogenic Telomerase-Mediated Therapy in Glioblastoma - A Duke and UTSW Collaboration$836,369
U19 · FY2025 · CA
Translational Cancer Biology (TCB) T32 Training Program$426,923
T32 · FY2025 · CA
Cancer Research Training and Education Coordination$243,163
P30 · FY2025 · CA · contact PI
6-thio-2'-deoxyguanosine: A Novel Immunogenic Telomerase-Mediated Therapy in Glioblastoma - A Duke and UTSW Collaboration$632,802
U19 · FY2024 · CA
Translational Cancer Biology (TCB) T32 Training Program$432,326
T32 · FY2024 · CA
Cancer Research Training and Education Coordination$162,197
P30 · FY2024 · CA · contact PI
6-thio-2'-deoxyguanosine: A Novel Immunogenic Telomerase-Mediated Therapy in Glioblastoma - A Duke and UTSW Collaboration$586,523
U19 · FY2023 · CA
Cancer Research Training and Education Coordination$162,197
P30 · FY2023 · CA · contact PI
6-thio-2'-deoxyguanosine: A Novel Immunogenic Telomerase-Mediated Therapy in Glioblastoma - A Duke and UTSW Collaboration$843,249
U19 · FY2022 · CA
Cancer Research Training and Education Coordination$162,197
P30 · FY2022 · CA · contact PI
6-thio-2'-deoxyguanosine: A Novel Immunogenic Telomerase-Mediated Therapy in Glioblastoma - A Duke and UTSW Collaboration$895,748
U19 · FY2021 · CA
Cancer Biology Training Grant$477,478
T32 · FY2021 · CA · contact PI
Cancer Research Training and Education Coordination$162,197
P30 · FY2021 · CA · contact PI
Cancer Biology Training Grant$474,813
T32 · FY2020 · CA · contact PI
Cancer Biology Training Grant$449,397
T32 · FY2019 · CA · contact PI
Cancer Biology Training Grant$428,010
T32 · FY2018 · CA · contact PI
Gene Expression in Aging and Development$394,250
R01 · FY2018 · AG · contact PI
Therapeutic Targeting of Telomerase in Lung Cancer Stem Cells$203,269
P50 · FY2018 · CA · contact PI
Cancer Biology Training Grant$289,881
T32 · FY2017 · CA · contact PI
Therapeutic Targeting of Telomerase in Lung Cancer Stem Cells$203,270
P50 · FY2017 · CA · contact PI
Cancer Biology Training Grant$384,841
T32 · FY2016 · CA · contact PI
Therapeutic Targeting of Telomerase in Lung Cancer Stem Cells$191,074
P50 · FY2016 · CA · contact PI
Cancer Biology Training Grant$371,713
T32 · FY2015 · CA · contact PI
Therapeutic Targeting of Telomerase in Lung Cancer Stem Cells$180,576
P50 · FY2015 · CA · contact PI
Cancer Biology Training Grant$389,436
T32 · FY2014 · CA · contact PI
Therapeutic Targeting of Telomerase in Lung Cancer Stem Cells$192,937
P50 · FY2014 · CA · contact PI
Cancer Biology Training Grant$363,359
T32 · FY2013 · CA · contact PI
P-4: Therapeutic Targeting of Telomerase and Lung Cancer$51,614
P50 · FY2013 · CA · contact PI
Cancer Biology Training Grant$321,872
T32 · FY2012 · CA · contact PI
P-4: Therapeutic Targeting of Telomerase and Lung Cancer$181,888
P50 · FY2012 · CA · contact PI
Cancer Biology Training Grant$237,562
T32 · FY2011 · CA · contact PI
P-4: Therapeutic Targeting of Telomerase and Lung Cancer$173,756
P50 · FY2011 · CA · contact PI
Cancer Biology Training Grant$278,845
T32 · FY2010 · CA · contact PI
P-4: Therapeutic Targeting of Telomerase and Lung Cancer$184,090
P50 · FY2010 · CA · contact PI
Cancer Biology Training Grant$251,358
T32 · FY2009 · CA · contact PI
P-4: Therapeutic Targeting of Telomerase and Lung Cancer$185,380
P50 · FY2009 · CA · contact PI
Cancer Biology Training Grant$278,659
T32 · FY2008 · CA · contact PI
P-4: Therapeutic Targeting of Telomerase and Lung Cancer$154,385
P50 · FY2008 · CA · contact PI
Cancer Biology Training Grant$273,263
T32 · FY2007 · CA · contact PI
The Role of Telomeres and Telomerase in Cancer$5,000
R13 · FY2005 · CA